Simple Summary Chemotherapy-induced peripheral neuropathy (CIPN) is a common side
effect of cancer treatment. It is experienced as numbness, tingling, pain, and cramping in the …

Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and dose-
limiting toxicity of many widely used chemotherapy regimens for the treatment of common …

Background No effective cures for chemotherapy-induced peripheral neuropathy (CIPN) are
known; however, exercise may be beneficial. Objective The purpose of this review was to …

Purpose Over half of all cancer patients receiving taxane-, platinum-, or vinca alkaloid-based
chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which …

Purpose To conduct a systematic review and meta-analysis of current studies to determine
whether exercise affects chemotherapy-induced peripheral neuropathy (CIPN) symptoms in …

Objectives: To evaluate for differences in demographic and clinical characteristics, as well
as subjective and objective measures of chemotherapy-induced peripheral neuropathy …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of
cancer therapy that often has negative implications on a patient's quality of life. The pain …

Purpose Summarize and critically evaluate the existing studies to determine the effects of
exercise on chemotherapy-induced peripheral neuropathy in cancer patients. Methods We …

Introduction Chemotherapy-induced peripheral neurotoxicity (CIPN) remains a significant
toxicity in cancer survivors without preventative strategies or rehabilitation. Exercise and …

Purpose Although exercise is recommended for cancer survivors with chemotherapy-
induced peripheral neuropathy (CIPN), the effective types of exercise for preventing and …